These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 21953616)
21. Quality control of prostate 1 H MRSI data. Wright AJ; Kobus T; Selnaes KM; Gribbestad IS; Weiland E; Scheenen TW; Heerschap A NMR Biomed; 2013 Feb; 26(2):193-203. PubMed ID: 22806985 [TBL] [Abstract][Full Text] [Related]
22. Quantitative (1) H MR spectroscopic imaging of the prostate gland using LCModel and a dedicated basis-set: correlation with histologic findings. García-Martín ML; Adrados M; Ortega MP; Fernández González I; López-Larrubia P; Viaño J; García-Segura JM Magn Reson Med; 2011 Feb; 65(2):329-39. PubMed ID: 20939087 [TBL] [Abstract][Full Text] [Related]
23. Combination of feature-reduced MR spectroscopic and MR imaging data for improved brain tumor classification. Simonetti AW; Melssen WJ; Szabo de Edelenyi F; van Asten JJ; Heerschap A; Buydens LM NMR Biomed; 2005 Feb; 18(1):34-43. PubMed ID: 15657908 [TBL] [Abstract][Full Text] [Related]
24. Three-dimensional proton magnetic resonance spectroscopic imaging with and without an endorectal coil: a prostate phantom study. Ma C; Chen L; Scheenen TW; Lu J; Wang J Acta Radiol; 2015 Nov; 56(11):1342-9. PubMed ID: 25348479 [TBL] [Abstract][Full Text] [Related]
25. Intraoperative conformal optimization for transperineal prostate implantation using magnetic resonance spectroscopic imaging. Zelefsky MJ; Cohen G; Zakian KL; Dyke J; Koutcher JA; Hricak H; Schwartz L; Zaider M Cancer J; 2000; 6(4):249-55. PubMed ID: 11038145 [TBL] [Abstract][Full Text] [Related]
26. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas. Stadlbauer A; Moser E; Gruber S; Buslei R; Nimsky C; Fahlbusch R; Ganslandt O Neuroimage; 2004 Oct; 23(2):454-61. PubMed ID: 15488395 [TBL] [Abstract][Full Text] [Related]
27. Using spatial prior knowledge in the spectral fitting of MRS images. Kelm BM; Kaster FO; Henning A; Weber MA; Bachert P; Boesiger P; Hamprecht FA; Menze BH NMR Biomed; 2012 Jan; 25(1):1-13. PubMed ID: 21538636 [TBL] [Abstract][Full Text] [Related]
28. Simple baseline correction for 1H MRSI data of the prostate. Wright AJ; Heerschap A Magn Reson Med; 2012 Dec; 68(6):1724-30. PubMed ID: 22294517 [TBL] [Abstract][Full Text] [Related]
29. [1H magnetic resonance spectroscopy of the prostate]. Mueller-Lisse UG; Scherr M Radiologe; 2003 Jun; 43(6):481-8. PubMed ID: 12827263 [TBL] [Abstract][Full Text] [Related]
30. Two-dimensional spectroscopic imaging for pretreatment evaluation of prostate cancer: comparison with the step-section histology after radical prostatectomy. Weis J; Ahlström H; Hlavcak P; Häggman M; Ortiz-Nieto F; Bergman A Magn Reson Imaging; 2009 Jan; 27(1):87-93. PubMed ID: 18599244 [TBL] [Abstract][Full Text] [Related]
31. Exploiting spatial information to estimate metabolite levels in two-dimensional MRSI of heterogeneous brain lesions. Croitor Sava AR; Sima DM; Poullet JB; Wright AJ; Heerschap A; Van Huffel S NMR Biomed; 2011 Aug; 24(7):824-35. PubMed ID: 21834006 [TBL] [Abstract][Full Text] [Related]
32. High-Quality 3-Dimensional 1H Magnetic Resonance Spectroscopic Imaging of the Prostate Without Endorectal Receive Coil Using A Semi-LASER Sequence. Tayari N; Steinseifer IK; Selnæs KM; Bathen TF; Maas MC; Heerschap A Invest Radiol; 2017 Oct; 52(10):640-646. PubMed ID: 28632688 [TBL] [Abstract][Full Text] [Related]
33. Optimal timing for in vivo 1H-MR spectroscopic imaging of the human prostate at 3T. Scheenen TW; Gambarota G; Weiland E; Klomp DW; Fütterer JJ; Barentsz JO; Heerschap A Magn Reson Med; 2005 Jun; 53(6):1268-74. PubMed ID: 15906304 [TBL] [Abstract][Full Text] [Related]
34. Detection of fully refocused polyamine spins in prostate cancer at 7 T. Klomp DW; Scheenen TW; Arteaga CS; van Asten J; Boer VO; Luijten PR NMR Biomed; 2011 Apr; 24(3):299-306. PubMed ID: 20925128 [TBL] [Abstract][Full Text] [Related]
35. Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP). Panebianco V; Sciarra A; Lisi D; Galati F; Buonocore V; Catalano C; Gentile V; Laghi A; Passariello R Eur J Radiol; 2012 Apr; 81(4):700-8. PubMed ID: 21330082 [TBL] [Abstract][Full Text] [Related]
36. Automatic frequency alignment and quantitation of single resonances in multiple magnetic resonance spectra via complex principal component analysis. Van Huffel S; Wang Y; Vanhamme L; Van Hecke P J Magn Reson; 2002; 158(1-2):1-14. PubMed ID: 12419666 [TBL] [Abstract][Full Text] [Related]
37. Deformable image registration for the use of magnetic resonance spectroscopy in prostate treatment planning. Wu X; Dibiase SJ; Gullapalli R; Yu CX Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1577-83. PubMed ID: 15050339 [TBL] [Abstract][Full Text] [Related]
38. Peripheral zone prostate cancer. Pre-treatment evaluation with MR and 3D ¹H MR spectroscopic imaging: correlation with pathologic findings. Giusti S; Caramella D; Fruzzetti E; Lazzereschi M; Tognetti A; Bartolozzi C Abdom Imaging; 2010 Dec; 35(6):757-63. PubMed ID: 19756851 [TBL] [Abstract][Full Text] [Related]
39. [Spectroscopic imaging (1H-2D-CSI) of the prostate: sequence optimization and correlation with histopathological results]. Stanka M; Eltze E; Semjonow A; Sievert KD; Maier A; Pfleiderer B Rofo; 2000 Jul; 172(7):623-9. PubMed ID: 10962989 [TBL] [Abstract][Full Text] [Related]
40. In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil. Kobus T; Hambrock T; Hulsbergen-van de Kaa CA; Wright AJ; Barentsz JO; Heerschap A; Scheenen TW Eur Urol; 2011 Nov; 60(5):1074-80. PubMed ID: 21419565 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]